Why would you put EIQ on a PE of 11-12 times? And for aortic stenosis only?
A med tech company like this, with the heart failure tech to come, would surely trade on a fwd PE of 20++ (like 30-40 times).
So even 20x, the formula for Market cap in those numbers is 8.5x20 = 170m USD = $253m AUD. i.e. further to go.
Add in the heart failure revenue and you're more like $48mx20 = 960m USD = $1.432b AUD i.e. bags to go.
Noting of course the heart failure part carries risk.
Ann: Major Milestone Achieved with FDA Clearance for EchoSolv AS, page-54
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $145.1M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $556.2K | 2.442M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 477271 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 41250 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |